A detailed history of Voya Investment Management LLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 13,279 shares of MORF stock, worth $756,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,279
Previous 12,158 9.22%
Holding current value
$756,770
Previous $427,000 5.85%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$26.12 - $34.07 $29,280 - $38,192
1,121 Added 9.22%
13,279 $452,000
Q1 2024

May 15, 2024

SELL
$26.64 - $40.31 $438,334 - $663,260
-16,454 Reduced 57.51%
12,158 $427,000
Q4 2023

Feb 14, 2024

BUY
$19.95 - $31.0 $13,246 - $20,584
664 Added 2.38%
28,612 $826,000
Q3 2023

Nov 14, 2023

SELL
$21.33 - $59.42 $531,842 - $1.48 Million
-24,934 Reduced 47.15%
27,948 $640,000
Q2 2023

Aug 14, 2023

BUY
$34.33 - $62.11 $1.06 Million - $1.92 Million
30,920 Added 140.79%
52,882 $3.03 Million
Q4 2022

Feb 14, 2023

SELL
$24.14 - $30.37 $860,953 - $1.08 Million
-35,665 Reduced 61.89%
21,962 $587,000
Q3 2022

Mar 03, 2023

BUY
$22.23 - $33.37 $792,832 - $1.19 Million
35,665 Added 162.39%
57,627 $1.63 Million
Q3 2022

Nov 14, 2022

BUY
$22.23 - $33.37 $1.07 Million - $1.6 Million
48,088 Added 504.12%
57,627 $1.63 Million
Q2 2022

Aug 15, 2022

BUY
$19.74 - $43.01 $19,522 - $42,536
989 Added 11.57%
9,539 $207,000
Q1 2022

May 16, 2022

BUY
$36.25 - $52.02 $12,470 - $17,894
344 Added 4.19%
8,550 $343,000
Q4 2021

Feb 14, 2022

BUY
$43.27 - $65.72 $1,687 - $2,563
39 Added 0.48%
8,206 $389,000
Q2 2021

Aug 16, 2021

BUY
$45.13 - $64.99 $96,397 - $138,818
2,136 Added 35.42%
8,167 $469,000
Q1 2021

May 17, 2021

BUY
$29.77 - $84.85 $476 - $1,357
16 Added 0.27%
6,031 $382,000
Q4 2020

Feb 16, 2021

BUY
$25.66 - $34.55 $154,344 - $207,818
6,015 New
6,015 $202,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.